Mishima Kazuo

写真a

Affiliation

Graduate School of Medicine  Doctorial Course in Medicine  Bioregulatory Medicine  Department of Neuropsychiatry

Research Interests 【 display / non-display

  • Psychiatry

  • Chronobiology

  • 精神神経科学/時間生物学/分子遺伝学/睡眠/加齢変化/精神薬理学的研究

Graduating School 【 display / non-display

  •  
    -
    1987.03

    Akita University   Faculty of Medicine   Graduated

Campus Career 【 display / non-display

  • 2018.09
    -
    Now

    Akita University   Graduate School of Medicine   Doctorial Course in Medicine   Bioregulatory Medicine   Professor  

Research Areas 【 display / non-display

  • Life Science / Psychiatry

  • Life Science / Neuroscience-general

 

Research Achievements 【 display / non-display

    ◆Original paper【 display / non-display

  • Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia

    Aoki, Y. Takaesu, Y. Matsui, K. Tokumasu, T. Tani, H. Takekita, Y. Kanazawa, T. Kishimoto, T. Tarutani, S. Hashimoto, N. Takeuchi, H. Mishima, K. Inada, K.

    Neuropsychopharmacol Rep ( Wiley )    2023.07  [Refereed]

    Research paper (journal)   Domestic Co-author

    DOI

  • Clinical practice for unspecified anxiety disorder in primary care

    Sakurai, H. Takeshima, M. Inada, K. Aoki, Y. Ie, K. Kise, M. Yoshida, E. Tsuboi, T. Yamada, H. Hori, H. Inada, Y. Shimizu, E. Mishima, K. Watanabe, K. Takaesu, Y.

    Psychiatry and Clinical Neurosciences Reports ( Wiley )  2 ( 3 )   2023.06  [Refereed]

    Research paper (journal)   Domestic Co-author

    DOI

  • The Relationship between Insomnia and Lifestyle-Related Diseases among Japanese Male Truck Drivers.

    Tomoka Ando, Takashi Miyachi, Yuta Sugano, Makoto Kamatsuka, Kazuo Mishima, Kyoko Nomura

    The Tohoku journal of experimental medicine     2023.06  [Refereed]

    Research paper (journal)   Domestic Co-author

    DOI PubMed

  • Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic

    Yumi Aoki, Yoshikazu Takaesu, Ken Inada, Hiroki Yamada, Tomohiko Murao, Toshiaki Kikuchi, Masahiro Takeshima, Masayuki Tani, Kazuo Mishima, Tempei Otsubo

    Frontiers in Psychiatry ( Frontiers Media SA )  14   2023.05  [Refereed]

    Research paper (journal)   Domestic Co-author

    Aim

    We aimed to develop a decision aid (DA) for individuals with anxiety disorders who consider tapering benzodiazepine (BZD) anxiolytics, and if tapering, tapering BZD anxiolytics with or without cognitive behavioral therapy (CBT) for anxiety. We also assessed its acceptability among stakeholders.

    Methods

    First, we conducted a literature review regarding anxiety disorders to determine treatment options. We cited the results of the systematic review and meta-analysis, which we conducted previously, to describe the related outcomes of two options: tapering BZD anxiolytics with CBT and tapering BZD anxiolytics without CBT. Second, we developed a DA prototype in accordance with the International Patient Decision Aid Standards. We carried out a mixed methods survey to assess the acceptability among stakeholders including those with anxiety disorders and healthcare providers.

    Results

    Our DA provided information such as explanation of anxiety disorders, options of tapering or not tapering BZD anxiolytics (if tapering, the options of tapering BZD anxiolytics with or without CBT) for anxiety disorder, benefits and risks of each option, and a worksheet for value clarification. For patients (n = 21), the DA appeared to be acceptable language (86%), adequate information (81%), and well-balanced presentation (86%). The developed DA was also acceptable for healthcare providers (n = 10).

    Conclusion

    We successfully created a DA for individuals with anxiety disorders who consider tapering BZD anxiolytics, which was acceptable for both patients and healthcare providers. Our DA was designed to assist patients and healthcare providers to involve decision-making about whether to taper BZD anxiolytics or not.

    DOI

  • A Comparison between Perceptions of Psychiatric Outpatients and Psychiatrists Regarding Benzodiazepine Use and Decision Making for Its Discontinuation: A Cross-Sectional Survey in Japan

    Yumi Aoki, Masahiro Takeshima, Takashi Tsuboi, Eiichi Katsumoto, Ken Udagawa, Ken Inada, Koichiro Watanabe, Kazuo Mishima, Yoshikazu Takaesu

    International Journal of Environmental Research and Public Health ( MDPI AG )  20 ( 7 ) 5373 - 5373   2023.04  [Refereed]

    Research paper (journal)   Domestic Co-author

    Background: Although long-term use of benzodiazepines and z-drugs (BZDs) is not recommended, little is known about the stakeholders’ perceptions. This study aimed to assess and compare the perceptions of BZD use and decision making regarding its discontinuation between psychiatric outpatients and psychiatrists. Methods: A cross-sectional survey was conducted. Results: Of 104 outpatients, 92% were taking hypnotics and 96% were taking anxiolytics for ≥a year, while 49% were willing to taper hypnotic/anxiolytics within a year of starting. Most psychiatrists felt that “patient and psychiatrist make the decision together on an equal basis” compared to patients (p < 0.001), while more patients felt that “the decision is (was) made considering the psychiatrists’ opinion” compared to psychiatrists (p < 0.001). Of 543 psychiatrists, 79% reported “patients were not willing to discontinue hypnotic/anxiolytic” whereas a certain number of patients conveyed “psychiatrists did not explain in enough detail about hypnotic/anxiolytic discontinuation such as procedure (18.3%), timing (19.2%), and appropriate condition (14.4%)”. Conclusion: The results suggest that the majority of psychiatric outpatients were taking hypnotic/anxiolytics for a long time against their will. There might be a difference in perceptions toward hypnotic/anxiolytic use and decision making for its discontinuation between psychiatric outpatients and psychiatrists. Further research is necessary to fill this gap.

    DOI

  • display all >>

    ◆Introduction and explanation【 display / non-display

  • Efficacy and safety of lithium and lamotrigine for the bipolar disorder in the maintenance phase: A systematic review and meta-analysis.

    岸太郎, 江角悟, 大矢一登, 奥谷理, 佐久間健二, 野村郁雄, 橋本保彦, 波多野正和, 波多野正和, 松井佑樹, 松田勇紀, 三宅誕実, 三島和夫, 岩田仲生

    臨床精神薬理   24 ( 9 ) 937 - 942   2021

    Introduction and explanation (scientific journal)   Domestic Co-author

    J-GLOBAL

  • How to use, reduce, and stop hypnotics after insomnia remission

      22 ( 8 ) 815 - 820   2019.08

    Introduction and explanation (scientific journal)  

  • Non-visual Effects of Light : Influence on alertness and cognitive function

      61 ( 8 ) 883 - 889   2019.08

    Introduction and explanation (scientific journal)  

  • 【知っておきたい器質性・症状性・薬剤性の精神障害:Update】抗NMDA受容体脳炎

    筒井 幸, 馬越 秋瀬, 神林 崇, 田中 惠子, 清水 徹男, 三島 和夫

    臨床精神医学 ( (株)アークメディア )  48 ( 1 ) 11 - 16   2019.01

    Introduction and explanation (scientific journal)  

  • Clinical Significance of the Clinical Practice Guideline for Proper Use and Cessation of Hypnotics

      60 ( 9 ) 949 - 956   2018.09

    Introduction and explanation (scientific journal)   Single author

    DOI CiNii Research

  • display all >>

    ◆Other【 display / non-display

  • Association of stay-home order during COVID-19 pandemic with depressive symptoms and suicide-related ideation in university students in Japan

    野村恭子, 南園佐知子, 前田恵理, KIM Roseline, 岩田豊人, 平山純子, 尾野恭一, 伏見雅人, 後藤猛, 三島和夫, 山本文雄

    日本心身医学会総会ならびに学術講演会抄録集   62nd (CD-ROM)   2021

    Summary of the papers read (national conference and other science council)   Domestic Co-author

    J-GLOBAL

  • 睡眠・覚醒相後退障害に対する心理社会支援プログラム開発の試み

    綾部直子, 吉村道孝, 栗山健一, 三島和夫, 三島和夫

    日本睡眠環境学会学術大会抄録集   28th   106   2019.09

    Summary of the papers read (national conference and other science council)  

    J-GLOBAL

  • 精神科学と神経免疫学のクロストーク 精神科領域からみた自己免疫性辺縁系脳炎

    筒井 幸, 馬越 秋瀬, 奥口 悠紀, 神林 崇, 田中 惠子, 清水 徹男, 三島 和夫

    精神神経学雑誌 ( (公社)日本精神神経学会 )  ( 2019特別号 ) S340 - S340   2019.06

    Summary of the papers read (national conference and other science council)  

  • 向精神薬の処方がもたらす転倒骨折リスクに関する薬剤疫学調査

    北村真吾, 榎本みのり, 三井寺浩幸, 立森久照, 三島和夫

    国立精神・神経医療研究センター精神保健研究所年報   ( 30 ) 235   2017.10

    Summary of the papers read (national conference and other science council)  

    J-GLOBAL

  • 多施設共同RCTによる不眠症に対する認知行動療法(Cognitive Behavioral Therapy for Insomnia:CBT‐I)の有効性

    綾部直子, 鈴木みのり, 立森久照, 北村真吾, 亀井雄一, 三島和夫

    国立精神・神経医療研究センター精神保健研究所年報   ( 30 ) 235   2017.10

    Summary of the papers read (national conference and other science council)  

    J-GLOBAL

  • display all >>

Books 【 display / non-display

  • Tasman’s Psychiatry

    三島和夫

    Springer  2023.01

Grant-in-Aid for Scientific Research 【 display / non-display

  • Grant-in-Aid for Scientific Research(B)

    Project Year: 2023.04  -  Now 

  • Construction and feature analysis of a model for predicting clinical outcomes of psychiatric disorders using sleep, behavioral, and physiological parameters.

    Grant-in-Aid for Scientific Research(B)

    Project Year: 2022.04  -  2025.03 

  • Grant-in-Aid for Scientific Research(B)

    Project Year: 2019.04  -  2022.03 

  • Grant-in-Aid for Scientific Research(B)

    Project Year: 2016.04  -  2019.03 

  • Grant-in-Aid for Scientific Research(S)

    Project Year: 2015.04  -  2016.03 

display all >>

 

Academic Activity 【 display / non-display

  • 2020.10
    -
    Now

  • 2020.10
    -
    Now

  • 2020.03
    -
    Now